Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/88126
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer
Author: Smit, E.
Burgers, S.
Biesma, B.
Smit, H.
Eppinga, P.
Dingemans, A.
Joerger, M.
Schellens, J.
Vincent, A.
van Zandwijk, N.
Groen, H.
Citation: Journal of Clinical Oncology, 2009; 27(12):2038-2045
Publisher: American Society of Clinical Oncology
Issue Date: 2009
ISSN: 0732-183X
1527-7755
Statement of
Responsibility: 
Egbert F. Smit, Sjaak A. Burgers, Bonne Biesma, Hans J.M. Smit, Pier Eppinga, Anne-Marie C. Dingemans, Markus Joerger, Jan H. Schellens, Andrew Vincent, Nico van Zandwijk, and Harry J.M. Groen
Abstract: Abstract not available
Keywords: Humans
Adenocarcinoma
Carcinoma, Large Cell
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Lung Neoplasms
Disease Progression
Carboplatin
Guanine
gamma-Glutamyl Hydrolase
Methylenetetrahydrofolate Reductase (NADPH2)
Thymidylate Synthase
Glutamates
Membrane Transport Proteins
Antineoplastic Combined Chemotherapy Protocols
Neoplasm Staging
Prognosis
Treatment Outcome
Survival Rate
Risk Factors
Follow-Up Studies
Pharmacogenetics
Polymorphism, Genetic
Adult
Aged
Aged, 80 and over
Middle Aged
Female
Male
Reduced Folate Carrier Protein
Pemetrexed
Rights: © 2009 by American Society of Clinical Oncology
DOI: 10.1200/JCO.2008.19.1650
Published version: http://dx.doi.org/10.1200/jco.2008.19.1650
Appears in Collections:Aurora harvest 7
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.